Literature DB >> 9554277

The role of cytotoxic T-cells in HIV infection.

S Rowland-Jones1, T Dong, P Krausa, J Sutton, H Newell, K Ariyoshi, F Gotch, S Sabally, T Corrah, J Kimani, K MacDonald, F Plummer, J Ndinya-Achola, H Whittle, A McMichael.   

Abstract

HIV-specific cytotoxic T lymphocytes (CTL) are believed to play a major role in controlling virus levels through the asymptomatic period of HIV infection. For the rational design of an HIV vaccine, we need to know whether protective immunity can ever develop following HIV exposure in people who remain uninfected. We have detected HIV-specific CTL in 5/6 repeatedly exposed, persistently seronegative female sex-workers in The Gambia. Their CTL, repeatedly detected over two years, recognise epitopes presented by HLA-B35 which are cross-reactive between HIV-1 & HIV-2, suggesting they could have been primed first by HIV-2 exposure and subsequently boosted by exposure to HIV-1. Using previously identified clade B HIV-1 epitope peptides, we have now detected HIV-specific CTL in 6/15 highly exposed and apparently HIV-resistant Kenyan prostitutes, predominantly towards epitopes highly conserved between B and the Kenyan A & D clades of HIV-1. This CTL activity towards conserved virus epitopes may represent protective immunity to HIV generated in response to repeated exposure, and prophylactic HIV vaccines should aim to generate similar CTL responses.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Behavior; Biology; Clinical Research; Cytology; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Gambia; Hiv Infections; Immunity; Immunity, Cellular; Immunological Effects; Kenya; Physiology; Prostitutes--women; Research Methodology; Research Report; Sex Behavior; Vaccines; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1998        PMID: 9554277

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  5 in total

1.  Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells.

Authors:  J Lisziewicz; D I Gabrilovich; G Varga; J Xu; P D Greenberg; S K Arya; M Bosch; J P Behr; F Lori
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells.

Authors:  Stefania Lenna; Danyelle M Townsend; Filemon K Tan; Bagrat Kapanadze; Malgorzata Markiewicz; Maria Trojanowska; Raffaella Scorza
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

3.  Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes.

Authors:  Leslie E Walker; Lo Vang; Xuefei Shen; Brian D Livingston; Penny Post; Alessandro Sette; C Steven Godin; Mark J Newman
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

Review 4.  HIV-1 group M conserved elements vaccine.

Authors:  Morgane Rolland; David C Nickle; James I Mullins
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

5.  Immunogenic Properties of MVs Containing Structural Hantaviral Proteins: An Original Study.

Authors:  Layaly Shkair; Ekaterina Evgenevna Garanina; Ekaterina Vladimirovna Martynova; Alena Igorevna Kolesnikova; Svetlana Sergeevna Arkhipova; Angelina Andreevna Titova; Albert Anatolevich Rizvanov; Svetlana Francevna Khaiboullina
Journal:  Pharmaceutics       Date:  2022-01-01       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.